1. Hutter MM, Schirmer BD, Jones DB, et al. 2011;First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass.
Ann Surg 254:410–420.
2. Lee SY, Lim CH, Pasupathy S, et al. 2011;Laparoscopic sleeve gastrectomy: a novel procedure for weight loss.
Singapore Med J 52:794–800.
3. Yousseif A, Emmanuel J, Karra E, et al. 2014;Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans.
Obes Surg 24:241–252.
4. Aggarwal S, Kini SU, Herron DM. 2007;Laparoscopic sleeve gastrectomy for morbid obesity: a review.
Surg Obes Relat Dis 3:189–194.
5. Bohdjalian A, Langer FB, Shakeri-Leidenmühler S, et al. 2010;Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin.
Obes Surg 20:535–540.
6. Himpens J, Dobbeleir J, Peeters G. 2010;Long-term results of laparoscopic sleeve gastrectomy for obesity.
Ann Surg 252:319–324.
7. Kaska L, Sledzinski T, Chomiczewska A, Dettlaff-Pokora A, Swierczynski J. 2016;Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome.
World J Gastroenterol 22:8698–8719.
8. Nauta FL, Boertien WE, Bakker SJ, et al. 2011;Glomerular and tubular damage markers are elevated in patients with diabetes.
Diabetes Care 34:975–981.
9. Nejat M, Pickering JW, Walker RJ, Endre ZH. 2010;Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit.
Nephrol Dial Transplant 25:3283–3289.
10. de Geus HR, Bakker J, Lesaffre EM, le Noble JL. 2011;Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients.
Am J Respir Crit Care Med 183:907–914.
11. Liang XL, Liu SX, Chen YH, et al. 2010;Combination of urinary kidney injury molecule-1 and interleukin-18 as early biomarker for the diagnosis and progressive assessment of acute kidney injury following cardiopulmonary bypass surgery: a prospective nested case-control study.
Biomarkers 15:332–339.
12. Emlet DR, Pastor-Soler N, Marciszyn A, et al. 2017;Insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinases-2: differential expression and secretion in human kidney tubule cells.
Am J Physiol Renal Physiol 312:F284–F296.
13. Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV. 2006;Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury.
Am J Physiol Renal Physiol 290:F517–F529.
14. Yin C, Wang N. 2016;Kidney injury molecule-1 in kidney disease.
Ren Fail 38:1567–1573.
15. Hanas R, John G. International HbA(1c) Consensus Committee. 2010;2010 Consensus statement on the worldwide standardization of the hemoglobin A(1c) measurement.
Clin Chem Lab Med 48:775–776.
16. Talke H, Schubert GE. 1965 [Enzymatic urea determination in the blood and serum in the warburg optical test].
Klin Wochenschr 43:174–175. German.
17. Kageyama N. 1971;A direct colorimetric determination of uric acid in serum and urine with uricase-catalase system.
Clin Chim Acta 31:421–426.
18. Bartels H, Böhmer M, Heierli C. 1972 [Serum creatinine determination without protein precipitation].
Clin Chim Acta 37:193–197. German.
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. 1999;A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group.
Ann Intern Med 130:461–470.
20. Salazar DE, Corcoran GB. 1988;Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass.
Am J Med 84:1053–1060.
21. Landau S, Everitt BS. 2004. A handbook of statistical analyses using SPSS. Chapman & Hall/CRC; Boca Raton:
22. English WJ, DeMaria EJ, Brethauer SA, Mattar SG, Rosenthal RJ, Morton JM. 2018;American Society for Metabolic and Bariatric Surgery estimation of metabolic and bariatric procedures performed in the United States in 2016.
Surg Obes Relat Dis 14:259–263.
23. Mingrone G, Panunzi S, De Gaetano A, et al. 2012;Bariatric surgery versus conventional medical therapy for type 2 diabetes.
N Engl J Med 366:1577–1585.
24. Schauer PR, Bhatt DL, Kirwan JP, et al. STAMPEDE Investigators. 2017;Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes.
N Engl J Med 376:641–651.
25. Sachdev P, Makaya T, Marven SS, Ackroyd R, Wales JK, Wright NP. 2014;Bariatric surgery in severely obese adolescents: a single-centre experience.
Arch Dis Child 99:894–898.
26. Kalinowski P, Paluszkiewicz R, Wróblewski T, et al. 2017;Ghrelin, leptin, and glycemic control after sleeve gastrectomy versus Roux-en-Y gastric bypass-results of a randomized clinical trial.
Surg Obes Relat Dis 13:181–188.
27. Adams ST, Salhab M, Hussain ZI, Miller GV, Leveson SH. 2013;Roux-en-Y gastric bypass for morbid obesity: what are the preoperative predictors of weight loss?
Postgrad Med J 89:411–416.
28. Jambhekar A, Maselli A, Robinson S, Kabata K, Gorecki P. 2018;Demographics and socioeconomic status as predictors of weight loss after laparoscopic sleeve gastrectomy: a prospective cohort study.
Int J Surg 54(Pt A):163–169.
29. Benaiges D, Flores Le-Roux JA, Pedro-Botet J, et al. 2013;Sleeve gastrectomy and Roux-en-Y gastric bypass are equally effective in correcting insulin resistance.
Int J Surg 11:309–313.
30. Holcomb CN, Goss LE, Almehmi A, Grams JM, Corey BL. 2018;Bariatric surgery is associated with renal function improvement.
Surg Endosc 32:276–281.
31. Navarro-Díaz M, Serra A, Romero R, et al. 2006;Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up.
J Am Soc Nephrol 17(12 Suppl 3):S213–S217.
32. Kim EY, Kim YJ. 2016;Does bariatric surgery really prevent deterioration of renal function?
Surg Obes Relat Dis 12:856–861.
33. Neff KJ, Frankel AH, Tam FW, Sadlier DM, Godson C, le Roux CW. 2013;The effect of bariatric surgery on renal function and disease: a focus on outcomes and inflammation.
Nephrol Dial Transplant 28(Suppl 4):iv73–iv82.
34. Park S, Kim YJ, Choi CY, Cho NJ, Gil HW, Lee EY. 2018;Bariatric surgery can reduce albuminuria in patients with severe obesity and normal kidney function by reducing systemic inflammation.
Obes Surg 28:831–837.
35. Scheven L, Joosten MM, de Jong PE, Bakker SJ, Gansevoort RT. PREVEND study group. 2014;The association of albuminuria with tubular reabsorption of uric acid: results from a general population cohort.
J Am Heart Assoc 3:e000613.
36. Goknar N, Oktem F, Ozgen IT, et al. 2015;Determination of early urinary renal injury markers in obese children.
Pediatr Nephrol 30:139–144.
37. Thomas MC, Burns WC, Cooper ME. 2005;Tubular changes in early diabetic nephropathy.
Adv Chronic Kidney Dis 12:177–186.
38. Xiao N, Devarajan P, Inge TH, Jenkins TM, Bennett M, Mitsnefes MM. 2015;Subclinical kidney injury before and 1 year after bariatric surgery among adolescents with severe obesity.
Obesity (Silver Spring) 23:1234–1238.
39. Chang AR, Grams ME, Navaneethan SD. 2017;Bariatric surgery and kidney-related outcomes.
Kidney Int Rep 2:261–270.
40. Li K, Zou J, Ye Z, et al. 2016;Effects of bariatric surgery on renal function in obese patients: a systematic review and meta analysis.
PLoS One 11:e0163907.